Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-18 8:56 pm Purchase |
2025-02-10 | 13D | Sionna Therapeutics, Inc. SION |
TPG GP A, LLC | 6,684,962 15.200% |
6,684,962 (New Position) |
Filing History |
| 2025-02-18 4:59 pm Purchase |
2025-02-10 | 13D | Sionna Therapeutics, Inc. SION |
Atlas Venture Fund XI, L.P. | 2,886,293 6.500% |
2,886,293 (New Position) |
Filing History |
| 2025-02-18 4:25 pm Purchase |
2025-02-10 | 13D | Sionna Therapeutics, Inc. SION |
RA Capital Management, L.P. | 10,445,322 23.700% |
10,445,322 (New Position) |
Filing History |
| 2025-02-18 4:22 pm Purchase |
2025-02-10 | 13D | Sionna Therapeutics, Inc. SION |
Enavate Sciences GP, LLC | 2,478,030 5.600% |
2,478,030 (New Position) |
Filing History |
| 2025-02-14 4:58 pm Purchase |
2025-02-10 | 13G | Sionna Therapeutics, Inc. SION |
VIKING GLOBAL INVESTORS LP | 2,952,754 6.700% |
2,952,754 (New Position) |
Filing History |
| 2025-02-13 4:47 pm Purchase |
2025-02-10 | 13D | Sionna Therapeutics, Inc. SION |
ORBIMED ADVISORS LLC | 3,704,959 8.400% |
3,704,959 (New Position) |
Filing History |